In a post on Truth Social, President Donald Trump said, “I am pleased to announce the new leadership of the Centers for Disease Control and Prevention (CDC). It is my Honor to nominate the incredibly talented Dr. Erica Schwartz, MD, JD, MPH, as my Director of the CDC. Erica graduated from Brown University for College and Medical School, and served a distinguished career as a Doctor of Medicine in the United States Military, the Greatest and Most Powerful Force in the World, and then served as my Deputy Surgeon General during my First Term. She is a STAR! I am also pleased to announce the appointment of Sean Slovenski as the CDC Deputy Director and Chief Operating Officer, Dr. Jennifer Shuford, MD, MPH, as the CDC Deputy Director and Chief Medical Officer, and Dr. Sara Brenner, MD, MPH, as Senior Counselor for Public Health to Secretary Robert F. Kennedy, Jr.” Publicly traded companies in the pharma and biotechnology space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY), Sanofi (SNY), Novo Nordisk (NVO), Amgen (AMGN), Gilead (GILD), Regeneron (REGN), Thermo Fisher (TMO), and Vertex (VRTX).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Best ETFs to Invest In, According to AI Analyst, 4/16/2026
- Trump Trade: White House launches space nuclear initiative
- Johnson & Johnson Stock Forecast: Trending Bullish Among Analysts
- Drugmakers raised prices on hundreds of drugs, NBC News reports
- MeiraGTx announces acquisition of bota-vec for treatment of XLRP
